Vanguard Personalized Indexing Management, LLC Tango Therapeutics, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.61 Billion
- Q1 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 10,632 shares of TNGX stock, worth $20,626. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,632Holding current value
$20,626% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding TNGX
# of Institutions
123Shares Held
98MCall Options Held
1.1KPut Options Held
0-
Trv Gp Iv, LLC Boston, MA16.9MShares$32.7 Million88.92% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA10.7MShares$20.8 Million3.54% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA10.6MShares$20.6 Million1.14% of portfolio
-
Nextech Invest, Ltd. Zurich, V85.53MShares$10.7 Million1.76% of portfolio
-
Nextech Invest Ag5.53MShares$10.7 Million3.19% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $171M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...